nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR2C—metabolic syndrome X	0.591	1	CbGaD
Aripiprazole—Muscle strain—Metformin—metabolic syndrome X	0.0137	0.0899	CcSEcCtD
Aripiprazole—White blood cell count increased—Metformin—metabolic syndrome X	0.00855	0.0562	CcSEcCtD
Aripiprazole—HTR7—sympathetic nervous system—metabolic syndrome X	0.00676	0.0803	CbGeAlD
Aripiprazole—HTR2A—arteriole—metabolic syndrome X	0.00662	0.0786	CbGeAlD
Aripiprazole—Viral diarrhoea—Metformin—metabolic syndrome X	0.00658	0.0432	CcSEcCtD
Aripiprazole—Abnormal faeces—Metformin—metabolic syndrome X	0.00601	0.0395	CcSEcCtD
Aripiprazole—Sinus headache—Metformin—metabolic syndrome X	0.00527	0.0346	CcSEcCtD
Aripiprazole—HTR7—autonomic nervous system—metabolic syndrome X	0.00454	0.054	CbGeAlD
Aripiprazole—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00422	0.0501	CbGeAlD
Aripiprazole—Tooth abscess—Metformin—metabolic syndrome X	0.00411	0.027	CcSEcCtD
Aripiprazole—Emotional distress—Metformin—metabolic syndrome X	0.00404	0.0265	CcSEcCtD
Aripiprazole—Abdominal bloating—Metformin—metabolic syndrome X	0.0036	0.0237	CcSEcCtD
Aripiprazole—Sinus congestion—Metformin—metabolic syndrome X	0.00345	0.0227	CcSEcCtD
Aripiprazole—HTR1B—artery—metabolic syndrome X	0.00334	0.0397	CbGeAlD
Aripiprazole—HTR1D—artery—metabolic syndrome X	0.00323	0.0384	CbGeAlD
Aripiprazole—Azotaemia—Metformin—metabolic syndrome X	0.00322	0.0212	CcSEcCtD
Aripiprazole—Loose stools—Metformin—metabolic syndrome X	0.0031	0.0204	CcSEcCtD
Aripiprazole—Hypothermia—Metformin—metabolic syndrome X	0.00306	0.0201	CcSEcCtD
Aripiprazole—Body temperature decreased—Metformin—metabolic syndrome X	0.00306	0.0201	CcSEcCtD
Aripiprazole—HTR2A—autonomic nervous system—metabolic syndrome X	0.00283	0.0337	CbGeAlD
Aripiprazole—Toothache—Metformin—metabolic syndrome X	0.00282	0.0185	CcSEcCtD
Aripiprazole—Respiratory distress—Metformin—metabolic syndrome X	0.0027	0.0178	CcSEcCtD
Aripiprazole—Upset stomach—Metformin—metabolic syndrome X	0.00262	0.0172	CcSEcCtD
Aripiprazole—HTR1B—blood vessel—metabolic syndrome X	0.0026	0.0309	CbGeAlD
Aripiprazole—HTR7—artery—metabolic syndrome X	0.00258	0.0306	CbGeAlD
Aripiprazole—HTR1D—blood vessel—metabolic syndrome X	0.00252	0.0299	CbGeAlD
Aripiprazole—HTR7—endothelium—metabolic syndrome X	0.00218	0.0259	CbGeAlD
Aripiprazole—Rhinorrhoea—Metformin—metabolic syndrome X	0.00212	0.0139	CcSEcCtD
Aripiprazole—HTR7—blood vessel—metabolic syndrome X	0.00201	0.0239	CbGeAlD
Aripiprazole—Contusion—Metformin—metabolic syndrome X	0.00197	0.0129	CcSEcCtD
Aripiprazole—Chest discomfort—Metformin—metabolic syndrome X	0.00194	0.0127	CcSEcCtD
Aripiprazole—Accidental injury—Metformin—metabolic syndrome X	0.00194	0.0127	CcSEcCtD
Aripiprazole—Neuropathy—Metformin—metabolic syndrome X	0.00161	0.0106	CcSEcCtD
Aripiprazole—HTR2A—artery—metabolic syndrome X	0.00161	0.0191	CbGeAlD
Aripiprazole—Lightheadedness—Metformin—metabolic syndrome X	0.00154	0.0101	CcSEcCtD
Aripiprazole—ADRA1B—kidney—metabolic syndrome X	0.0015	0.0179	CbGeAlD
Aripiprazole—Ear pain—Metformin—metabolic syndrome X	0.00146	0.0096	CcSEcCtD
Aripiprazole—H1F0—cardiovascular system—metabolic syndrome X	0.00145	0.0172	CbGeAlD
Aripiprazole—H1F0—kidney—metabolic syndrome X	0.00142	0.0169	CbGeAlD
Aripiprazole—Nasal congestion—Metformin—metabolic syndrome X	0.00137	0.00899	CcSEcCtD
Aripiprazole—HTR2A—endothelium—metabolic syndrome X	0.00136	0.0161	CbGeAlD
Aripiprazole—Injury—Metformin—metabolic syndrome X	0.00136	0.00891	CcSEcCtD
Aripiprazole—H1F0—adipose tissue—metabolic syndrome X	0.00128	0.0152	CbGeAlD
Aripiprazole—Hypoglycaemia—Metformin—metabolic syndrome X	0.00128	0.00839	CcSEcCtD
Aripiprazole—Lethargy—Metformin—metabolic syndrome X	0.00127	0.00835	CcSEcCtD
Aripiprazole—Ziprasidone—HTR2C—metabolic syndrome X	0.00127	0.262	CrCbGaD
Aripiprazole—HTR2A—blood vessel—metabolic syndrome X	0.00125	0.0149	CbGeAlD
Aripiprazole—Pain in extremity—Metformin—metabolic syndrome X	0.00125	0.00819	CcSEcCtD
Aripiprazole—Migraine—Metformin—metabolic syndrome X	0.00123	0.00806	CcSEcCtD
Aripiprazole—CYP3A7—liver—metabolic syndrome X	0.00121	0.0144	CbGeAlD
Aripiprazole—HTR1B—cardiovascular system—metabolic syndrome X	0.00116	0.0138	CbGeAlD
Aripiprazole—Dehydration—Metformin—metabolic syndrome X	0.00116	0.00761	CcSEcCtD
Aripiprazole—CHRM2—cardiovascular system—metabolic syndrome X	0.00115	0.0137	CbGeAlD
Aripiprazole—Liver function test abnormal—Metformin—metabolic syndrome X	0.00115	0.00756	CcSEcCtD
Aripiprazole—Abdominal pain upper—Metformin—metabolic syndrome X	0.00114	0.00748	CcSEcCtD
Aripiprazole—Breast disorder—Metformin—metabolic syndrome X	0.00113	0.0074	CcSEcCtD
Aripiprazole—HTR1D—cardiovascular system—metabolic syndrome X	0.00112	0.0134	CbGeAlD
Aripiprazole—Cramp muscle—Metformin—metabolic syndrome X	0.00112	0.00737	CcSEcCtD
Aripiprazole—Nasopharyngitis—Metformin—metabolic syndrome X	0.00111	0.00732	CcSEcCtD
Aripiprazole—HTR1D—kidney—metabolic syndrome X	0.0011	0.0131	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—metabolic syndrome X	0.00109	0.013	CbGeAlD
Aripiprazole—Abdominal distension—Metformin—metabolic syndrome X	0.00108	0.00712	CcSEcCtD
Aripiprazole—Influenza—Metformin—metabolic syndrome X	0.00108	0.00708	CcSEcCtD
Aripiprazole—Nefazodone—HTR2C—metabolic syndrome X	0.00107	0.22	CrCbGaD
Aripiprazole—Pancreatitis—Metformin—metabolic syndrome X	0.00106	0.00694	CcSEcCtD
Aripiprazole—CHRM1—cardiovascular system—metabolic syndrome X	0.00105	0.0125	CbGeAlD
Aripiprazole—Angina pectoris—Metformin—metabolic syndrome X	0.00105	0.00689	CcSEcCtD
Aripiprazole—HTR2B—cardiovascular system—metabolic syndrome X	0.00105	0.0124	CbGeAlD
Aripiprazole—Abdominal discomfort—Metformin—metabolic syndrome X	0.00103	0.00678	CcSEcCtD
Aripiprazole—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.00103	0.0122	CbGeAlD
Aripiprazole—Neutropenia—Metformin—metabolic syndrome X	0.00101	0.00662	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.001	0.00658	CcSEcCtD
Aripiprazole—Trazodone—HTR2C—metabolic syndrome X	0.000986	0.204	CrCbGaD
Aripiprazole—ADRB1—adipose tissue—metabolic syndrome X	0.000963	0.0114	CbGeAlD
Aripiprazole—Infestation NOS—Metformin—metabolic syndrome X	0.00096	0.00631	CcSEcCtD
Aripiprazole—Infestation—Metformin—metabolic syndrome X	0.00096	0.00631	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000941	0.00618	CcSEcCtD
Aripiprazole—HTR1A—cardiovascular system—metabolic syndrome X	0.000937	0.0111	CbGeAlD
Aripiprazole—HTR2B—adipose tissue—metabolic syndrome X	0.000922	0.011	CbGeAlD
Aripiprazole—CHRM3—kidney—metabolic syndrome X	0.00092	0.0109	CbGeAlD
Aripiprazole—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000908	0.00597	CcSEcCtD
Aripiprazole—H1F0—liver—metabolic syndrome X	0.000897	0.0107	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—metabolic syndrome X	0.000895	0.0106	CbGeAlD
Aripiprazole—Prochlorperazine—HTR2C—metabolic syndrome X	0.000883	0.183	CrCbGaD
Aripiprazole—Bradycardia—Metformin—metabolic syndrome X	0.000877	0.00577	CcSEcCtD
Aripiprazole—HTR7—kidney—metabolic syndrome X	0.000876	0.0104	CbGeAlD
Aripiprazole—Rhinitis—Metformin—metabolic syndrome X	0.000864	0.00568	CcSEcCtD
Aripiprazole—ADRA1A—cardiovascular system—metabolic syndrome X	0.000864	0.0103	CbGeAlD
Aripiprazole—Hepatitis—Metformin—metabolic syndrome X	0.000862	0.00566	CcSEcCtD
Aripiprazole—Hypoaesthesia—Metformin—metabolic syndrome X	0.000858	0.00564	CcSEcCtD
Aripiprazole—Oedema peripheral—Metformin—metabolic syndrome X	0.000849	0.00558	CcSEcCtD
Aripiprazole—Connective tissue disorder—Metformin—metabolic syndrome X	0.000847	0.00557	CcSEcCtD
Aripiprazole—KCNH2—cardiovascular system—metabolic syndrome X	0.000834	0.00991	CbGeAlD
Aripiprazole—CHRM3—adipose tissue—metabolic syndrome X	0.000829	0.00986	CbGeAlD
Aripiprazole—ABCB1—blood vessel—metabolic syndrome X	0.00082	0.00975	CbGeAlD
Aripiprazole—Eye disorder—Metformin—metabolic syndrome X	0.000805	0.00529	CcSEcCtD
Aripiprazole—ADRA2C—kidney—metabolic syndrome X	0.000805	0.00957	CbGeAlD
Aripiprazole—Cardiac disorder—Metformin—metabolic syndrome X	0.0008	0.00526	CcSEcCtD
Aripiprazole—Flushing—Metformin—metabolic syndrome X	0.0008	0.00526	CcSEcCtD
Aripiprazole—Angiopathy—Metformin—metabolic syndrome X	0.000782	0.00514	CcSEcCtD
Aripiprazole—Immune system disorder—Metformin—metabolic syndrome X	0.000778	0.00512	CcSEcCtD
Aripiprazole—Mediastinal disorder—Metformin—metabolic syndrome X	0.000777	0.0051	CcSEcCtD
Aripiprazole—Chills—Metformin—metabolic syndrome X	0.000773	0.00508	CcSEcCtD
Aripiprazole—ADRA1A—adipose tissue—metabolic syndrome X	0.000762	0.00905	CbGeAlD
Aripiprazole—Erythema—Metformin—metabolic syndrome X	0.00075	0.00493	CcSEcCtD
Aripiprazole—Malnutrition—Metformin—metabolic syndrome X	0.00075	0.00493	CcSEcCtD
Aripiprazole—Flatulence—Metformin—metabolic syndrome X	0.000739	0.00486	CcSEcCtD
Aripiprazole—Dysgeusia—Metformin—metabolic syndrome X	0.000735	0.00483	CcSEcCtD
Aripiprazole—ADRA2C—adipose tissue—metabolic syndrome X	0.000726	0.00863	CbGeAlD
Aripiprazole—Muscle spasms—Metformin—metabolic syndrome X	0.000721	0.00474	CcSEcCtD
Aripiprazole—Vision blurred—Metformin—metabolic syndrome X	0.000707	0.00465	CcSEcCtD
Aripiprazole—Tremor—Metformin—metabolic syndrome X	0.000703	0.00462	CcSEcCtD
Aripiprazole—Ill-defined disorder—Metformin—metabolic syndrome X	0.000696	0.00457	CcSEcCtD
Aripiprazole—Malaise—Metformin—metabolic syndrome X	0.000677	0.00445	CcSEcCtD
Aripiprazole—CYP3A5—kidney—metabolic syndrome X	0.000674	0.00801	CbGeAlD
Aripiprazole—Syncope—Metformin—metabolic syndrome X	0.000673	0.00442	CcSEcCtD
Aripiprazole—Palpitations—Metformin—metabolic syndrome X	0.000663	0.00436	CcSEcCtD
Aripiprazole—Loss of consciousness—Metformin—metabolic syndrome X	0.000659	0.00433	CcSEcCtD
Aripiprazole—Hypertension—Metformin—metabolic syndrome X	0.000648	0.00426	CcSEcCtD
Aripiprazole—Chest pain—Metformin—metabolic syndrome X	0.000639	0.0042	CcSEcCtD
Aripiprazole—Myalgia—Metformin—metabolic syndrome X	0.000639	0.0042	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000634	0.00417	CcSEcCtD
Aripiprazole—Perphenazine—HTR2C—metabolic syndrome X	0.000631	0.131	CrCbGaD
Aripiprazole—Discomfort—Metformin—metabolic syndrome X	0.000631	0.00415	CcSEcCtD
Aripiprazole—Oedema—Metformin—metabolic syndrome X	0.000612	0.00402	CcSEcCtD
Aripiprazole—Infection—Metformin—metabolic syndrome X	0.000608	0.004	CcSEcCtD
Aripiprazole—CYP3A5—adipose tissue—metabolic syndrome X	0.000607	0.00722	CbGeAlD
Aripiprazole—Shock—Metformin—metabolic syndrome X	0.000602	0.00396	CcSEcCtD
Aripiprazole—Nervous system disorder—Metformin—metabolic syndrome X	0.0006	0.00395	CcSEcCtD
Aripiprazole—Thrombocytopenia—Metformin—metabolic syndrome X	0.0006	0.00394	CcSEcCtD
Aripiprazole—Skin disorder—Metformin—metabolic syndrome X	0.000595	0.00391	CcSEcCtD
Aripiprazole—Hyperhidrosis—Metformin—metabolic syndrome X	0.000592	0.00389	CcSEcCtD
Aripiprazole—HRH1—adipose tissue—metabolic syndrome X	0.00059	0.00701	CbGeAlD
Aripiprazole—Anorexia—Metformin—metabolic syndrome X	0.000584	0.00384	CcSEcCtD
Aripiprazole—ADRA2A—adipose tissue—metabolic syndrome X	0.000579	0.00688	CbGeAlD
Aripiprazole—Hypotension—Metformin—metabolic syndrome X	0.000572	0.00376	CcSEcCtD
Aripiprazole—HTR2A—cardiovascular system—metabolic syndrome X	0.000558	0.00664	CbGeAlD
Aripiprazole—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000558	0.00367	CcSEcCtD
Aripiprazole—HTR7—liver—metabolic syndrome X	0.000554	0.00658	CbGeAlD
Aripiprazole—Paraesthesia—Metformin—metabolic syndrome X	0.00055	0.00361	CcSEcCtD
Aripiprazole—HTR2A—kidney—metabolic syndrome X	0.000546	0.00649	CbGeAlD
Aripiprazole—Dyspnoea—Metformin—metabolic syndrome X	0.000546	0.00359	CcSEcCtD
Aripiprazole—Somnolence—Metformin—metabolic syndrome X	0.000544	0.00358	CcSEcCtD
Aripiprazole—Dyspepsia—Metformin—metabolic syndrome X	0.000539	0.00354	CcSEcCtD
Aripiprazole—ADRA1A—liver—metabolic syndrome X	0.000534	0.00635	CbGeAlD
Aripiprazole—Decreased appetite—Metformin—metabolic syndrome X	0.000532	0.0035	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000529	0.00347	CcSEcCtD
Aripiprazole—Fatigue—Metformin—metabolic syndrome X	0.000528	0.00347	CcSEcCtD
Aripiprazole—Constipation—Metformin—metabolic syndrome X	0.000524	0.00344	CcSEcCtD
Aripiprazole—ADRA2C—liver—metabolic syndrome X	0.000509	0.00605	CbGeAlD
Aripiprazole—CYP3A4—kidney—metabolic syndrome X	0.000506	0.00601	CbGeAlD
Aripiprazole—Feeling abnormal—Metformin—metabolic syndrome X	0.000505	0.00332	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000501	0.00329	CcSEcCtD
Aripiprazole—CYP2D6—kidney—metabolic syndrome X	0.000498	0.00591	CbGeAlD
Aripiprazole—Urticaria—Metformin—metabolic syndrome X	0.000486	0.0032	CcSEcCtD
Aripiprazole—Abdominal pain—Metformin—metabolic syndrome X	0.000484	0.00318	CcSEcCtD
Aripiprazole—Asthenia—Metformin—metabolic syndrome X	0.000439	0.00289	CcSEcCtD
Aripiprazole—Pruritus—Metformin—metabolic syndrome X	0.000433	0.00285	CcSEcCtD
Aripiprazole—CYP3A5—liver—metabolic syndrome X	0.000426	0.00506	CbGeAlD
Aripiprazole—Diarrhoea—Metformin—metabolic syndrome X	0.000419	0.00275	CcSEcCtD
Aripiprazole—Dizziness—Metformin—metabolic syndrome X	0.000405	0.00266	CcSEcCtD
Aripiprazole—Vomiting—Metformin—metabolic syndrome X	0.000389	0.00256	CcSEcCtD
Aripiprazole—Rash—Metformin—metabolic syndrome X	0.000386	0.00254	CcSEcCtD
Aripiprazole—Dermatitis—Metformin—metabolic syndrome X	0.000386	0.00253	CcSEcCtD
Aripiprazole—Headache—Metformin—metabolic syndrome X	0.000384	0.00252	CcSEcCtD
Aripiprazole—ABCB1—cardiovascular system—metabolic syndrome X	0.000366	0.00435	CbGeAlD
Aripiprazole—Nausea—Metformin—metabolic syndrome X	0.000364	0.00239	CcSEcCtD
Aripiprazole—ABCB1—kidney—metabolic syndrome X	0.000358	0.00425	CbGeAlD
Aripiprazole—HTR2A—liver—metabolic syndrome X	0.000345	0.0041	CbGeAlD
Aripiprazole—ABCB1—adipose tissue—metabolic syndrome X	0.000323	0.00383	CbGeAlD
Aripiprazole—CYP3A4—liver—metabolic syndrome X	0.00032	0.0038	CbGeAlD
Aripiprazole—CYP2D6—liver—metabolic syndrome X	0.000315	0.00374	CbGeAlD
Aripiprazole—ABCB1—liver—metabolic syndrome X	0.000226	0.00269	CbGeAlD
Aripiprazole—CYP3A4—Metabolism—APOC3—metabolic syndrome X	8.51e-06	5.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	8.5e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	8.49e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—LPL—metabolic syndrome X	8.48e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	8.44e-06	5.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	8.43e-06	5.02e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	8.41e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—NOS3—metabolic syndrome X	8.39e-06	5e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	8.38e-06	4.99e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.37e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOB—metabolic syndrome X	8.37e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	8.36e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	8.31e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	8.28e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CETP—metabolic syndrome X	8.26e-06	4.92e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	8.25e-06	4.92e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	8.24e-06	4.91e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PPARG—metabolic syndrome X	8.21e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—INS—metabolic syndrome X	8.2e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	8.19e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	8.17e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.17e-06	4.86e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	8.15e-06	4.85e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	8.14e-06	4.85e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	8.13e-06	4.84e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	8.07e-06	4.81e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—INS—metabolic syndrome X	8.07e-06	4.81e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	8.07e-06	4.81e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CD36—metabolic syndrome X	8.06e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.06e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—INS—metabolic syndrome X	8.06e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—metabolic syndrome X	8.05e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—INS—metabolic syndrome X	8.05e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	8.04e-06	4.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—INS—metabolic syndrome X	8.03e-06	4.78e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—INS—metabolic syndrome X	8e-06	4.77e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—LPL—metabolic syndrome X	7.99e-06	4.76e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	7.94e-06	4.73e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	7.94e-06	4.73e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	7.93e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	7.93e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—INS—metabolic syndrome X	7.93e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	7.93e-06	4.72e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	7.91e-06	4.71e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	7.9e-06	4.71e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	7.9e-06	4.7e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	7.87e-06	4.69e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	7.86e-06	4.68e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	7.81e-06	4.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	7.8e-06	4.65e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	7.8e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	7.79e-06	4.64e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	7.78e-06	4.63e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	7.78e-06	4.63e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	7.77e-06	4.63e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	7.74e-06	4.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—NOS3—metabolic syndrome X	7.7e-06	4.59e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	7.68e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PTGS2—metabolic syndrome X	7.68e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	7.67e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	7.67e-06	4.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	7.65e-06	4.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CD36—metabolic syndrome X	7.59e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.54e-06	4.49e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARA—metabolic syndrome X	7.49e-06	4.46e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	7.47e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GOT2—metabolic syndrome X	7.47e-06	4.45e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	7.45e-06	4.44e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	7.42e-06	4.42e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.41e-06	4.42e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.4e-06	4.41e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—metabolic syndrome X	7.38e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.38e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	7.35e-06	4.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	7.34e-06	4.37e-05	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.34e-06	4.37e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	7.32e-06	4.36e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	7.32e-06	4.36e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	7.31e-06	4.35e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.28e-06	4.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.27e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	7.26e-06	4.33e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.26e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AGT—metabolic syndrome X	7.26e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	7.23e-06	4.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	7.23e-06	4.3e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	7.19e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	7.16e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—metabolic syndrome X	7.15e-06	4.26e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.11e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOE—metabolic syndrome X	7.11e-06	4.23e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	7.1e-06	4.23e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	7.08e-06	4.22e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	7.06e-06	4.21e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARA—metabolic syndrome X	7.06e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—NOS3—metabolic syndrome X	7.06e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	7.04e-06	4.2e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	7.04e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOA1—metabolic syndrome X	7.03e-06	4.19e-05	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.02e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	7.02e-06	4.18e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	7e-06	4.17e-05	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	6.99e-06	4.16e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	6.95e-06	4.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	6.93e-06	4.13e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	6.91e-06	4.12e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	6.91e-06	4.11e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	6.88e-06	4.1e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AGT—metabolic syndrome X	6.84e-06	4.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	6.79e-06	4.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.75e-06	4.02e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—metabolic syndrome X	6.7e-06	3.99e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	6.69e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	6.69e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.68e-06	3.98e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	6.67e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	6.66e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	6.66e-06	3.97e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOA1—metabolic syndrome X	6.62e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	6.61e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	6.61e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	6.59e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	6.58e-06	3.92e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	6.46e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GGT1—metabolic syndrome X	6.45e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GOT1—metabolic syndrome X	6.45e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	6.44e-06	3.84e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.38e-06	3.8e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.34e-06	3.78e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	6.3e-06	3.75e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	6.22e-06	3.7e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—metabolic syndrome X	6.19e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.17e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.17e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—metabolic syndrome X	6.07e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	6.07e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	6.07e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.07e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.05e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.03e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	6.01e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	5.97e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	5.96e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	5.96e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.94e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	5.94e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	5.92e-06	3.53e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	5.86e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	5.85e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—metabolic syndrome X	5.84e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—metabolic syndrome X	5.72e-06	3.41e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	5.66e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	5.61e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	5.6e-06	3.33e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—metabolic syndrome X	5.57e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.52e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—metabolic syndrome X	5.52e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—metabolic syndrome X	5.51e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.51e-06	3.28e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	5.5e-06	3.27e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	5.48e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	5.47e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.47e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	5.46e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	5.43e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.42e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	5.41e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.39e-06	3.21e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.39e-06	3.21e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	5.36e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—metabolic syndrome X	5.33e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.32e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—metabolic syndrome X	5.27e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.25e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.24e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.23e-06	3.11e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	5.2e-06	3.1e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	5.16e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.09e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	5.08e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.05e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	5.03e-06	3e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.02e-06	2.99e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.01e-06	2.98e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	4.98e-06	2.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CD36—metabolic syndrome X	4.97e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	4.94e-06	2.94e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—metabolic syndrome X	4.87e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	4.87e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	4.8e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	4.76e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—metabolic syndrome X	4.75e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—metabolic syndrome X	4.68e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.68e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	4.67e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	4.66e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	4.64e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	4.64e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARA—metabolic syndrome X	4.62e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	4.6e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	4.6e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	4.59e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.58e-06	2.73e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—metabolic syndrome X	4.49e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.47e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.38e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—metabolic syndrome X	4.36e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.33e-06	2.58e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	4.32e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	4.27e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.26e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.23e-06	2.52e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.08e-06	2.43e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.06e-06	2.42e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	3.95e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	3.94e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	3.9e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	3.89e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—metabolic syndrome X	3.86e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.82e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	3.77e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	3.75e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—metabolic syndrome X	3.74e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	3.64e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.59e-06	2.14e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.58e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.54e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.53e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—metabolic syndrome X	3.52e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	3.51e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	3.5e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	3.46e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.45e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.43e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.31e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.28e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.25e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.25e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—metabolic syndrome X	3.24e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.24e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.23e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.21e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.2e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.19e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	2.96e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.45e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.31e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.51e-06	8.98e-06	CbGpPWpGaD
